that "Dr. Burzynski's patients will be irrep- arably harmed if this Court [the district court) fails to require the FDA to grant IND status to the Antineoplaston Al0 com- pound ... in that many patients who could be helped by the use of antineoplastons will be denied their Constitutional right of ac- cess to